Cellular signal transduction by anandamide and 2-arachidonoylglycerol

Chemistry and Physics of Lipids

Volumn 108, Issue 1-2, 2000, Pages 53-70

  Howlett, Allyn C ^a   Mukhopadhyay, Somnath ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenylyl cyclase; G proteins; Gap junctions; Intracellular Ca2+; Ion channels; Vanilloid receptors

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CALCIUM CHANNEL; CALCIUM ION; CANNABINOID RECEPTOR; FOCAL ADHESION KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL; RECEPTOR SUBTYPE; VANILLOID RECEPTOR;

CALCIUM CELL LEVEL; CALCIUM CURRENT; CARDIOVASCULAR AUTOREGULATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME INHIBITION; GAP JUNCTION; GENE INDUCTION; HUMAN; IMMEDIATE EARLY GENE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACIDS; CALCIUM; GAP JUNCTIONS; GLYCERIDES; HUMANS; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SIGNAL TRANSDUCTION;

EID: 0033647159     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(00)00187-0     Document Type: Review

References (95)

1. Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides
2. The peripheral cannabinoid receptor: Adenylate cyclase inhibition and G protein coupling
3. 9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells
4. 2 cannabinoid receptors: Pharmacology of the carbonyl and ethanolamide groups
5. Nonclassical and endogenous cannabinoids: Effects on the ordering of brain membranes
6. Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide
7. Arachidonic acid amide inhibitors of gap junction cell-cell communication
8. Cerebrodiene, arachidonyl ethanolamide, and hybrid structures: Potential for interaction with brain cannabinoid receptors
9. 1 induces krox-24 expression in human astrocytoma cells
10. 1
11. 2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinases and induction of Krox-24 expression
12. + exchanger NHE-1 isoform via G(i)-mediated mitogen activated protein kinase signaling transduction pathways
13. 35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity
14. 1 receptor agonists in the mouse brain
15. 1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries
16. The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication
17. 2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors
18. Role of cyclic AMP in the actions of cannabinoid receptors
19. Effects of anandamide on cannabinoid receptors in rat brain membranes
20. Tetrahydrocannabinol inhibition of macrophage nitric oxide production
21. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
22. Regulation of a neuronal form of focal adhesion kinase by anandamide
23. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines
24. Production and physiological actions of anandamide in the vasculature of the rat kidney
25. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
26. The endogenous cannabimimetic eicosanoid, anandamide, induces arachidonate release in J774 mouse macrophages
27. Interactions between synthetic vanilloids and the endogenous cannabinoid system
28. 3 receptors in rat nodose ganglion neurons
29. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones
30. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction
31. 2 receptors
32. Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: Coupling to nitric oxide release
33. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat
34. 2+ channel current
35. 35S]thio)-triphosphate binding assay in rat cerebellar membranes
36. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human Type 2 cannabinoid receptor: Antagonism by anandamide
37. The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells
38. Effects of cannabinoids on energy metabolism
39. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission
40. 1)
41. 1 receptors on peripheral sympathetic nerves
42. 3H]dihydropyridine binding and L-type calcium channel current
43. 2 receptors
44. Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice
45. Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes
46. 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-6B/Rel activation
47. Isolation, identification and synthesis of an endogenous arachidonic amide
48. 1 and the induction of GDP/GTP exchange
49. Anandamide stimulates phospholipase D activity in PC12 cells but not in NIH 3T3 fibroblasts
50. 1-like cannabinoid receptors
51. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats
52. 1 cannabinoid receptors in human vascular endothelial cells
53. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells
54. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor
55. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a Xenopus oocyte expression system
56. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
57. 1 cannabinoid receptors
58. Anandamide suppresses nitric oxide and TNF-Δ responses to Theiler's virus or endotoxin in astrocytes
59. 2+ in endothelial cells
60. 2+ signals in cerebellar granule neurons in culture
61. 1 cannabinoid receptors in the EDHF-dependent vasorelaxation in rabbits
62. Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain
63. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid
64. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries
65. + channels
66. 1 cannabinoid receptor
67. Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: Neurovascular regulation
68. 2) cannabinoid receptors
69. An endogenous cannabinoid as an endothelium-derived vasorelaxant
70. Involvement of cannabinoid in endothelium-derived hyperplacizing factor-mediated coronory vasorelaxation
71. Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery
72. 1 cannabinoid receptors in cultured astrocytes
73. 9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes
74. 2+ channel
75. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes
76. Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release
77. Identification and characterization of the leech CNS cannabinoid receptor: Coupling to nitric oxide release
78. Antagonism of LPS and IFN-(induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase
79. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
80. 2+ in neuroblastoma x glioma hybrid NG108-15 cells
81. 2+ transient in NG108-15 cells
82. Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells
83. 1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds
84. Vanilloid (capsaicin) receptors and mechanisms
85. 1 cannabinoid receptor in the hypotensive action of anandamide
86. Mechanism of the hypotensive action of anandamide in anesthetized rats
87. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes
88. (R)-methanandamide inhibits receptor-induced calcium responses by depleting internal calcium stores in cultured astrocytes
89. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase
90. 1 cannabinoid receptors in haemorrhagic shock
91. Cardiovascular actions of cannabinoids and their generation during shock
92. Mesenteric vasodilation mediated by endothelial anandamide receptors
93. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide
94. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery
95. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide